title: Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats.
abstract: We have tried to develop a new model consisting of rats transplanted with syngeneic colon carcinoma PROb cells transfected with cDNA coding for the carcinoembryonic antigen (CEA), the human tumor marker most commonly used as target for MAbs. The antigenic density of the 4 CEA-expressing clones selected for a precise characterization ranged from 5 x 10(4) to 1 x 10(6) CEA molecules per cell. In all clones the CEA was shown to be attached to the membrane by a phosphatidylinositol (PI) anchor. Using a panel of radiolabeled MAbs directed against the 5 major epitopes described on the CEA molecule, we showed that all these CEA epitopes were expressed by the 4 transfectants. Southern-blot analysis showed that the entire CEA cDNA was present in the transfectants. Western-blot analysis, however, showed that the size of the CEA expressed by the 4 transfectants was slightly smaller than that of CEA produced by 2 reference human colon-carcinoma cell lines. Two clones, expressing 1 x 10(5) and 1 x 10(6) CEA molecules per cell, respectively, were grafted s.c. in nude mice and rats. Injection of radiolabeled anti-CEA F(ab')2 fragments into these animals showed specific tumor localization with the highest percentages of injected doses for the transfectants expressing the highest CEA level. When grafted into immunocompetent syngeneic BDIX rats, the CEA-expressing clones induced a strong antibody response against CEA and tumor rejections in a majority of the animals. Although the analysis of the immune response against the CEA-cDNA-transfected carcinoma cells is under investigation, the present results demonstrate that human CEA could function as a rejection antigen when transfected into rat carcinoma cells.
authors.affiliation: Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Pèlegrin
authors.forename: A
authors.initials: A
authors.lastname: Terskikh
authors.forename: D
authors.initials: D
authors.lastname: Hayoz
authors.forename: Y
authors.initials: Y
authors.lastname: Chalandon
authors.forename: N O
authors.initials: NO
authors.lastname: Olsson
authors.forename: S
authors.initials: S
authors.lastname: Folli
authors.forename: F
authors.initials: F
authors.lastname: Buchegger
authors.forename: B
authors.initials: B
authors.lastname: Kromer
authors.forename: K
authors.initials: K
authors.lastname: Schwarz
authors.forename: M
authors.initials: M
authors.lastname: Martin
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000276:immunology*; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D001483:Base Sequence; D002272:Carcinoembryonic Antigen / Q000032:analysis / Q000235:genetics* / Q000276:immunology; D003110:Colonic Neoplasms / Q000235:genetics / Q000276:immunology*; D004247:DNA / Q000032:analysis*; D006084:Graft Rejection; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D008969:Molecular Sequence Data; D009368:Neoplasm Transplantation; D016719:Radioimmunodetection; D051381:Rats; D011923:Rats, Nude; D014162:Transfection
chemical_list: D000911:Antibodies, Monoclonal; D002272:Carcinoembryonic Antigen; D004247:DNA